Reversed Polarity Breast Cancer: Understanding Tall Cell Carcinoma
Tall cell carcinoma with reversed polarity (TCRP) is a distinct subtype of breast carcinoma, characterized by unique histopathological features and clinical behavior. First described by Lacroix-Tribollet et al. in 2014, it's crucial for pathologists and clinicians to recognize this entity for accurate diagnosis and tailored treatment.
TCRP typically occurs in postmenopausal women, with a median age of diagnosis around 70 years. It's often misdiagnosed as usual-type invasive ductal carcinoma, highlighting the importance of understanding its distinctive features.
Histopathological Characteristics of TCRP
Histopathologically, TCRP is defined by tall columnar cells with apical snouts, arranged in Indian file or inverted dramas. The cells exhibit reversed polarity, with basally located nuclei and apically situated cytoplasm, which secretes abundant mucus.
Immunohistochemically, TCRP is positive for mucin core proteins (MUC) 1 and 2, and epithelial membrane antigen (EMA). It's negative for basal/myoepithelial markers such as smooth muscle myosin heavy chain (SMMHC), p63, and calponin, distinguishing it from other basal-like carcinomas.
Distinct Clinicopathological Features of TCRP
Clinically, TCRP usually presents as a slow-growing, painless mass. It's often well-circumscribed and ill-defined, with a median size of 2.5 cm. On mammography, it may appear as a circumscribed, high-density mass, while on ultrasound, it's often depicted as a hypoechoic, heterogeneous mass with posterior acoustic enhancement.
Genomically, TCRP shares certain features with luminal A subtype, including low proliferation rate (Ki67 index <14%), and low TP53 mutation frequency. However, it harbors distinct gene expression profiles and nommeasurable structural variations, suggesting a unique oncogenic pathway.
Diagnosis and Treatment Strategies
Accurate diagnosis of TCRP is essential for optimal patient management. Core biopsy is the gold standard for diagnosis, withroscopic evaluation often revealing the distinctive cytomorphological features. Immunohistochemical stains can further confirm the diagnosis.
Surgical excision is the mainstay of treatment, with breast conserving therapy preferred when feasible. After surgery, adjuvant radiotherapy and hormone therapy, as per standard guidelines for stage and grade, are recommended.Chemotherapy is generally not indicated due to its low proliferation rate and low-risk profile.
Prognosis and Survival Rates
TCRP carries an excellent prognosis compared to other breast cancer subtypes. Five-year disease-free survival approaches 100%, and overall survival exceeds 90% in most series. This favorable prognosis could be attributed to its low-grade nature, low proliferative index, and early-stage presentation.
However, long-term follow-up is necessary, given the limited knowledge about its late recurrences and distant metastasis potential. Clinicians and pathologists should remain vigilant for any changes in the natural history of this disease with increasing data availability.
In conclusion, tall cell carcinoma with reversed polarity stands out as a unique breast carcinoma subtype, presenting distinctive histopathological features, clinical characteristics, and prognostic implications. Improving awareness among clinicians and pathologists can lead to better diagnosis and management strategies, ultimately benefiting patients. Ongoing research is vital to unraveling its exact oncogenesis, optimizing treatment paradigms, and enhancing our understanding of its natural history.